Prescription drug manufacturers have aggressively fought allegations implicating their semaglutide products
Common issues include nausea, vomiting, constipation, or diarrhea from GLP-1 agonists, and insomnia, dry mouth, or jitteriness from stimulants
Priority was given to recent publications and high-quality evidence, with emphasis on studies published after 2022 reflecting the evolving understanding of perioperative risks
Read on to learn more about these two weight loss meds, the results so far, and what potential side effects to expect
We were brought to voicemail, which explained that a customer service representative would call us back if we left our name and phone number